[1] |
Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?[J]. Nat Rev Microbiol, 2007, 5(11): 873-882.
doi: 10.1038/nrmicro1748
pmid: 17938629
|
[2] |
Editorial Board of the Chinese Journal of Infectious Diseases. Expert consensus on diagnosis and treatment of Leishmania infection in China[J]. Chin J Infect Dis, 2017, 35(9): 513-518. (in Chinese)
|
|
(《中华传染病杂志》编辑委员会. 中国利什曼原虫感染诊断和治疗专家共识[J]. 中华传染病杂志, 2017, 35(9): 513-518.)
|
[3] |
Zhou ZB, Li YY, Zhang Y, et al. Prevalence of visceral leishmaniasis in China in 2018[J]. Chin J Parasitol Parasit Dis, 2020, 38(2): 175-180, 187. (in Chinese)
|
|
(周正斌, 李元元, 张仪, 等. 2018年全国内脏利什曼病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 175-180, 187.)
|
[4] |
Han HZ, Shang WJ. Epidemic status of kala-azar in the Tibetan Autonomous Prefecture of Gannan in Gansu Province from 2005 to 2014[J]. Chin J Endem, 2015, 34(12): 917-919. (in Chinese)
|
|
(韩惠珍, 尚文杰. 2005—2014年甘肃省甘南藏族自治州黑热病流行现状分析[J]. 中华地方病学杂志, 2015, 34(12): 917-919.)
|
[5] |
Zhang FN, Zhang LP. Analysis on recurrence and death of leishmaniasis cases in Sichuan Province[J]. J Prev Med Inf, 2010, 26(12): 961-965. (in Chinese)
|
|
(张富南, 张丽萍. 四川省黑热病复发和死亡原因分析[J]. 预防医学情报杂志, 2010, 26(12): 961-965.)
|
[6] |
Lun ZR, Wu MS, Chen YF, et al. Visceral leishmaniasis in China: an endemic disease under control[J]. Clin Microbiol Rev, 2015, 28(4): 987-1004.
doi: 10.1128/CMR.00080-14
|
[7] |
Li YR, Liu XG, Feng HL. Epidemiological and clinical characteristics analysis of 23 patients with pediatric kala-azar[J]. Chin J Woman Child Health Res, 2013, 24(6): 879-881. (in Chinese)
|
|
(李亚绒, 刘小乖, 冯海琳. 儿童黑热病23例流行病学及临床特征分析[J]. 中国妇幼健康研究, 2013, 24(6): 879-881.)
|
[8] |
Ru L, Luo Q, Guo YF. Clinical analysis of children kala-azar in 26 cases[J]. J Xinjiang Med Univ, 2012, 35(3): 349-351, 354. (in Chinese)
|
|
(茹凉, 罗琼, 郭艳芳. 儿童黑热病26例临床分析[J]. 新疆医科大学学报, 2012, 35(3): 349-351, 354.)
|
[9] |
He F. Clinical analysis of 46 cases of childhood visceral leishmaniasis[J]. J Clin Pediatr, 2017, 35(3): 191-194. (in Chinese)
|
|
(何芳. 儿童黑热病46例临床分析[J]. 临床儿科杂志, 2017, 35(3): 191-194.)
|
[10] |
Kafetzis DA, Maltezou HC. Visceral leishmaniasis in paediatrics[J]. Curr Opin Infect Dis, 2002, 15(3): 289-294.
doi: 10.1097/00001432-200206000-00012
pmid: 12015464
|
[11] |
Zhang L, Zhang W, Chen SP, et al. Retrospective analysis of 4 cases of kala-azar diagnosed by bone marrow cell morphology[J]. Lab Med, 2021, 36(10): 1015-1017. (in Chinese)
|
|
(张磊, 张雯, 陈社平, 等. 骨髓细胞形态确诊黑热病4例回顾分析[J]. 检验医学, 2021, 36(10): 1015-1017.)
|
[12] |
Ashkan MM, Rahim KM. Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran[J]. Trop Doct, 2008, 38(3): 186-188.
doi: 10.1258/td.2007.070259
pmid: 18628558
|
[13] |
de Carvalho CA, Ferrão TF, et al. High levels of serum glycans monovalent IgG immune complexes detected by dissociative ELISA in experimental visceral leishmaniasis[J]. Immunology, 2019, 158(4): 314-321.
doi: 10.1111/imm.13118
pmid: 31576564
|
[14] |
Liu ZZ, Tang GM, Ye H, et al. Retrospective analysis of clinical diagnosis and treatment of 79 cases of kala-azar[J]. Clin Focus, 2015, 30(3): 316-318. (in Chinese)
|
|
(刘真真, 唐光敏, 叶慧, 等. 黑热病79例临床诊治回顾性分析[J]. 临床荟萃, 2015, 30(3): 316-318.)
|
[15] |
Chen XY, Yang LY, Zhao Y, et al. A study of the clinical application values of bone marrow examination and rK39 test strip in patients with sufferer performance[J]. Labeled Immunoass Clin Med, 2017, 24(11): 1252-1253, 1268. (in Chinese)
|
|
(陈曦阳, 杨柳莹, 赵仪, 等. 探讨骨髓检查和rK39试纸条方法对临床黑热病表现症患者检测效果[J]. 标记免疫分析与临床, 2017, 24(11): 1252-1253, 1268.)
|
[16] |
Miao RX, Wang ZL, Guo Q, et al. Clinical and epidemiologic features of visceral leishmaniasis in children in southwestern China: a retrospective analysis from 2001 to 2015[J]. Pediatr Infect Dis J, 2017, 36(1): 9-12.
pmid: 27749663
|
[17] |
Lu YW, Zhang XE. Clinical study on the treatment of children’s kala-azar with stilbene[J]. Chin Rural Health, 2017(22): 30. (in Chinese)
|
|
(路永文, 张小娥. 斯锑黑克应用于治疗儿童黑热病的临床研究[J]. 中国农村卫生, 2017(22): 30.)
|